Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice

Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-β/Smad3 pathway

(2015) Tongshuai Chen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Resveratrol inhibits high glucose induced collagen upregulation in cardiac fibroblasts through regulating TGF-β1–Smad3 signaling pathway

(2015) Junhui Liu et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Hypoxia-inducible factor-1α is required for transforming growth factor-β1-induced type I collagen, periostin and α-smooth muscle actin expression in human periodontal ligament cells

(2014) Teppei Watanabe et al.   ARCHIVES OF ORAL BIOLOGY

Kir6.2-containing ATP-sensitive K+ channel is required for cardioprotection of resveratrol in mice

(2014) Ren-Hong Du et al.   Cardiovascular Diabetology

Inhibition of Periostin Expression Protects against the Development of Renal Inflammation and Fibrosis

(2014) M. Mael-Ainin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The role of periostin in tissue remodeling across health and disease

(2013) Simon J. Conway et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis From Pressure Overload by Targeting NFAT (Nuclear Factor of Activated T-cells) Signaling and Periostin

(2013) Wei Liu et al.   Circulation-Heart Failure

Periostin as a modulator of chronic cardiac remodeling after myocardial infarction

(2013) MF Minicucci et al.   Clinics

Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes

(2013) Chin-Feng Tsai et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts

(2013) Sheng Zhao et al.   Journal of Cardiology

IGFBP5 mediates high glucose-induced cardiac fibroblast activation

(2013) Seung Eun Song et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Metformin Inhibits Angiotensin II-Induced Differentiation of Cardiac Fibroblasts into Myofibroblasts

(2013) Jian Bai et al.   PLoS One

Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis

(2012) Payal K. Naik et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions

(2012) Po-Hsun Huang et al.   Cardiovascular Diabetology

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid

(2012) Chun-jun Li et al.   Cardiovascular Diabetology

Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice

(2012) Ying Ann Chiao et al.   CARDIOVASCULAR RESEARCH

The Polyphenols Resveratrol and S17834 Prevent the Structural and Functional Sequelae of Diet-Induced Metabolic Heart Disease in Mice

(2012) Fuzhong Qin et al.   CIRCULATION

Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: Possible involvement of PKC–MAPK signaling pathway

(2012) Vivian Soetikno et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts

(2012) Jun Gu et al.   EXPERIMENTAL CELL RESEARCH

Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-  pathway

(2012) A. Lorts et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Periostin Is Induced in Glomerular Injury and Expressed de Novo in Interstitial Renal Fibrosis

(2011) Kontheari Sen et al.   AMERICAN JOURNAL OF PATHOLOGY

Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts

(2011) Li Li et al.   CARDIOVASCULAR RESEARCH

Resveratrol inhibits transforming growth factor-β–induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration

(2011) Evelina Fagone et al.   EXPERIMENTAL LUNG RESEARCH

Adenylyl Cyclase 6 Deletion Reduces Left Ventricular Hypertrophy, Dilation, Dysfunction, and Fibrosis in Pressure-Overloaded Female Mice

(2010) Tong Tang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dietary polyphenols: Focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis

(2010) A. Borriello et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing Heart

(2009) William E. Stansfield et al.   ANNALS OF THORACIC SURGERY

Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts

(2008) Kaliyamurthi Venkatachalam et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart

(2008) Paige Snider et al.   CIRCULATION RESEARCH

Periostin is essential for cardiac healingafter acute myocardial infarction

(2008) Masashi Shimazaki et al.   JOURNAL OF EXPERIMENTAL MEDICINE